Commonwealth Retirement Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$223K Hold
1,602
0.07% 120
2025
Q4
$197K Sell
1,602
-321
-17% -$39K 0.06% 125
2025
Q3
$213K Sell
1,923
-110
-5% -$12.5K 0.07% 117
2025
Q2
$225K Sell
2,033
-22,724
-92% -$2.42M 0.09% 110
2025
Q1
$2.77M Buy
24,757
+260
+1% +$26.8K 1.13% 27
2024
Q4
$2.26M Sell
24,497
-13
-0.1% -$1.17K 0.93% 36
2024
Q3
$2.05M Buy
24,510
+1,828
+8% +$139K 0.86% 38
2024
Q2
$1.56M Buy
+22,682
New +$1.51M 0.71% 45

Other funds holding GILD

Commonwealth Retirement Investments's GILD Position: Q1 2026 in Review

Commonwealth Retirement Investments held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,602 shares worth $223K. The position accounts for 0.07% of the portfolio, ranked #120.

Commonwealth Retirement Investments first reported a position in GILD in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.77M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Commonwealth Retirement Investments held 1,602 shares of Gilead Sciences worth $223K as of Q1 2026.
  • Commonwealth Retirement Investments left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.07% of Commonwealth Retirement Investments's portfolio in Q1 2026, its #120 holding.
  • Commonwealth Retirement Investments first reported a position in Gilead Sciences in Q2 2024 and has held it in 8 quarters since.
  • Commonwealth Retirement Investments's Gilead Sciences position peaked at $2.77M in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q1 2026, filed 11 May 2026.